NASDAQ

Akari Therapeutics Plc - American Depositary Shares (AKTX)

621 Thanks from members

Akari Therapeutics Plc (AKTX) displays a polarized profile characterized by a bullish retail sentiment score of 95/100, rising short interest, and novel oncology clinical progress balanced against severe going concern warnings and a larger Q2 net loss.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →